Mary Ann Liebert: Characterizing Antibodies Targeting Antisense Oligonucleotide Modifications
July 23, 2025
July 23, 2025
NEW ROCHELLE, New York, July 23 (TNSjou) -- Mary Ann Liebert Inc. posted the following news release:
* * *
Characterizing Antibodies Targeting Antisense Oligonucleotide Modifications
New Rochelle, NY, July 22, 2025--A new article in the peer-reviewed journal Nucleic Acid Therapeutics describes the characterization of antibodies targeting antisense oligonucleotide (ASO) phosphorothioate and 2'-methoxyehtyl modifications for intracellular trafficking and . . .
* * *
Characterizing Antibodies Targeting Antisense Oligonucleotide Modifications
New Rochelle, NY, July 22, 2025--A new article in the peer-reviewed journal Nucleic Acid Therapeutics describes the characterization of antibodies targeting antisense oligonucleotide (ASO) phosphorothioate and 2'-methoxyehtyl modifications for intracellular trafficking and . . .